Kratos Sales Up 36%, Free Cash Flow Negative: Rapid Earnings Reaction

Kratos’ third-quarter revenue rose 36% to $471.8 million (23% excluding acquisitions), and new orders were 2.2 times sales, lifting backlog to $2.65 billion from $2.08 billion at the end of Q2. GAAP operating income swung to a $4.9 million loss from $7.1 million of income a year earlier, while the company used $29.4 million of free cash in the quarter and expects $110 million–$120 million of free cash use this year. Kratos raised $1.35 billion through stock sales in nine months and plans to provide 2027 operating and free cash flow guidance in late February; shares slipped about 0.6% after hours.

Analysis

The key debate is conversion, not demand: a large order pipeline has limited equity value if it requires recurring external capital and fails to translate into operating cash. The widening gap between adjusted EBITDA and GAAP results makes the quality and persistence of add-backs important; investors should separate acquired-intangible amortization from capitalized contract/development costs, which may carry different implications for future cash needs. Equity issuance shifts some growth economics from existing holders to new capital providers and can cap per-share upside even as the business expands.

Over the next 1–3 months, the late-February 2027 cash-flow outlook is the central catalyst; a continuing resolution beyond March 31 is a specific risk to both timing and forecast credibility. Over 6–18 months, the bull case requires backlog conversion, improving cash generation, and less reliance on share issuance. A defense-spending tailwind alone does not resolve execution or dilution risk. Potential beneficiaries of any slippage in unmanned/defense programs include established primes and competing defense technology providers, but the article does not establish a direct transfer of awards.

Contrarian angle: strong demand may keep the stock supported, but investors could be underweighting the per-share cost of financing growth and the uncertainty around cash conversion. Conversely, the cash burn may be a deliberate investment phase; without valuation, share-count, and contract-level cash-conversion data, an outright short is not well supported.

Key Decisions for Investors

• Avoid chasing the order momentum; hold an underweight/relative-underweight stance on KTOS versus diversified defense exposure until management provides 2027 operating and free-cash-flow guidance in late February.
• Treat rallies ahead of that guidance as opportunities to reduce exposure rather than initiate a standalone short. Reassess if guidance shows credible cash-flow improvement without another material increase in share count.
• Monitor quarterly operating cash flow, share count and proceeds from equity issuance, and the composition of adjusted-EBITDA add-backs—especially capitalized contract and development costs. These are the tests of whether backlog is converting into per-share value.
• Falsify the cautious thesis if 2027 cash-flow guidance is credible, subsequent quarters show improving cash conversion, and the continuing-resolution risk does not delay program execution. Escalate caution if the funding gap widens or the March 31 budget risk forces guidance down.